GRAFT-VERSUS-HOST DISEASE, RELAPSE-FREE SURVIVAL (GRFS) IN OLDER PATIENTS WITH MYELOID MALIGNANCIES IS DETERMINED BY DISEASE STAGE AND DONOR AGE BUT NOT BY THE TYPE OF THE DONOR

被引：0
|
作者：
Jindra, Pavel [1 ]
Karas, Michal [2 ]
Cepek, Pavel [1 ]
Steinerova, Katerina [2 ]
Lysak, Daniel [2 ]
机构：
[1] Czech Natl Marrow Donors Registry, Plzen, Czech Republic
[2] Univ Hosp Plzen, Plzen, Czech Republic
来源：
HLA | 2019年 / 93卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P155
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [21] Dynamic Graft-Versus-Host Disease-Free, Relapse-Free Survival (dGRFS): Multistate Modeling of the Morbidity and Mortality of Allotransplantation
    Holtan, Sheman G.
    Zhang, Lin
    Defor, Todd E.
    Rashidi, Armin
    Bejanyan, Nelli
    Lazaryan, Aleksandr
    Kotiso, Florence
    MacMillan, Margaret L.
    Arora, Mukta
    Blazar, Bruce R.
    Wagner, John E.
    Brunstein, Claudio G.
    Weisdorf, Daniel J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S33 - S34
  • [22] Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
    Park, Sung-Soo
    Jeon, Young-Woo
    Min, Gi June
    Park, Silvia
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Yoo-Jin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 63 - 72
  • [23] POST-TRANSPLANTATION CYCLOPHOSPHAMIDE IMPROVES GRAFT-VERSUS-HOST DISEASE-FREE, RELAPSE-FREE SURVIVAL IN HLA-DPB1 MISMATCHED UNRELATED DONOR ALLOGENEIC TRANSPLANT
    McCurdy, Shannon R.
    Solomon, Scott R.
    Shaffer, Brian C.
    He, Meilun
    Bolon, Yung-Tsi
    Blouin, Amanda G.
    Keyzner, Alla
    Socola, Francisco A.
    Ibrahim, Uroosa
    Zou, Jun
    Safah, Hana
    Saba, Nakhle
    Gadalla, Shahinaz
    Perales, Miguel-Angel
    Paczesny, Sophie
    Marsh, Steven
    Petersdorf, Effie W.
    Wang, Tao
    Fuchs, Ephraim J.
    Lee, Stephanie J.
    BONE MARROW TRANSPLANTATION, 2024, 59 : 624 - 625
  • [24] Impact of the Difference in Body Mass Index at Transplantation from That at Diagnosis for Graft-Versus-Host Disease-Free, Relapse-Free Survival in Acute Myeloid Leukemia
    Ando, Taiki
    Yamazaki, Etsuko
    Teshigawara, Haruka
    Ogusa, Eriko
    Ishii, Yoshimi
    Miyashita, Kazuho
    Motohashi, Kenji
    Miyazaki, Takuya
    Tachibana, Takayoshi
    Hagihara, Maki
    Matsumoto, Kenji
    Tanaka, Masatsugu
    Hashimoto, Chizuko
    Koharazawa, Hideyuki
    Fujimaki, Katsumichi
    Taguchi, Jun
    Fujita, Hiroyuki
    Kanamori, Heiwa
    Fujisawa, Shin
    Nakajima, Hideaki
    BLOOD, 2016, 128 (22)
  • [25] NEURAMINIDASE PRETREATMENT OF DONOR LYMPHOCYTES AND GRAFT-VERSUS-HOST DISEASE
    STACEY, NH
    COX, J
    LOBLAY, R
    CROSBIE, J
    EXPERIMENTAL HEMATOLOGY, 1989, 17 (03) : 273 - 277
  • [26] Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies
    Passweg, Jakob R.
    Zhang, Mei-Jie
    Rocha, Vanderson
    Kan, Fangyu
    Champlin, Richard E.
    Isola, Luis M.
    Gee, Adrian P.
    Gibson, John
    Laughlin, Mary J.
    Lazarus, Hillard M.
    Loren, Alison
    Marks, David.
    Gratwohl, Alois
    Eapen, Mary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) : 1869 - 1873
  • [27] Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia
    Giorgia Battipaglia
    Annalisa Ruggeri
    Myriam Labopin
    Liisa Volin
    Didier Blaise
    Gerard Socié
    Reza Tabrizi
    Jan J. Cornelissen
    Ardeshir Ghavamzadeh
    Anne Huynh
    Depei Wu
    Ibrahim Yakoub-Agha
    Johan Maertens
    Patrice Chevallier
    Mohamad Mohty
    Arnon Nagler
    Bone Marrow Transplantation, 2018, 53 : 1295 - 1303
  • [28] High transplanted CD34+cells are not associated with beneficial effect on graft-versus-host disease-free, relapse-free survival (GRFS) after allogeneic hematopoietic cell transplantation
    Lee, Y.
    Lee, I. H.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S217 - S218
  • [29] Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia
    Battipaglia, Giorgia
    Ruggeri, Annalisa
    Labopin, Myriam
    Volin, Liisa
    Blaise, Didier
    Socie, Gerard
    Tabrizi, Reza
    Cornelissen, Jan J.
    Ghavamzadeh, Ardeshir
    Huynh, Anne
    Wu, Depei
    Yakoub-Agha, Ibrahim
    Maertens, Johan
    Chevallier, Patrice
    Mohty, Mohamad
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2018, 53 (10) : 1295 - 1303
  • [30] Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
    Remberger, Mats
    Tjonnfjord, Geir E.
    Abrahamsen, Ingerid W.
    Ali, Maryan
    Myhre, Anders E.
    Gedde-Dahl, Tobias
    Floisand, Yngvar
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (07): : 621.e1 - 621.e3
12345